Published in Appl Environ Microbiol on September 01, 1999
Interspecies interactions within oral microbial communities. Microbiol Mol Biol Rev (2007) 3.16
Mutation of luxS affects biofilm formation in Streptococcus mutans. Infect Immun (2003) 2.34
The group I strain of Streptococcus mutans, UA140, produces both the lantibiotic mutacin I and a nonlantibiotic bacteriocin, mutacin IV. Appl Environ Microbiol (2001) 2.11
Biosynthesis of the lantibiotic mersacidin: organization of a type B lantibiotic gene cluster. Appl Environ Microbiol (2000) 1.81
Genetic analysis of a unique bacteriocin, Smb, produced by Streptococcus mutans GS5. Antimicrob Agents Chemother (2005) 1.79
Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins. Appl Environ Microbiol (2009) 1.68
Inactivation of the ciaH Gene in Streptococcus mutans diminishes mutacin production and competence development, alters sucrose-dependent biofilm formation, and reduces stress tolerance. Infect Immun (2004) 1.62
Interactions between oral bacteria: inhibition of Streptococcus mutans bacteriocin production by Streptococcus gordonii. Appl Environ Microbiol (2005) 1.59
Bacteriocin diversity in Streptococcus and Enterococcus. J Bacteriol (2006) 1.57
Purification and biochemical characterization of mutacin I from the group I strain of Streptococcus mutans, CH43, and genetic analysis of mutacin I biosynthesis genes. Appl Environ Microbiol (2000) 1.53
The response regulator ComE in Streptococcus mutans functions both as a transcription activator of mutacin production and repressor of CSP biosynthesis. Microbiology (2007) 1.48
Production of the lantibiotic salivaricin A and its variants by oral streptococci and use of a specific induction assay to detect their presence in human saliva. Appl Environ Microbiol (2006) 1.37
Bacteriocin (mutacin) production by Streptococcus mutans genome sequence reference strain UA159: elucidation of the antimicrobial repertoire by genetic dissection. Appl Environ Microbiol (2005) 1.31
Comparative genomic analyses of Streptococcus mutans provide insights into chromosomal shuffling and species-specific content. BMC Genomics (2009) 1.29
Identification of nlmTE, the locus encoding the ABC transport system required for export of nonlantibiotic mutacins in Streptococcus mutans. J Bacteriol (2005) 1.21
Crystal structure of the peptidyl-cysteine decarboxylase EpiD complexed with a pentapeptide substrate. EMBO J (2000) 1.15
Production of the Bsa lantibiotic by community-acquired Staphylococcus aureus strains. J Bacteriol (2009) 1.13
The mutacins of Streptococcus mutans: regulation and ecology. Mol Oral Microbiol (2011) 1.10
Regulation of bacteriocin production and cell death by the VicRK signaling system in Streptococcus mutans. J Bacteriol (2012) 1.09
An extracelluar protease, SepM, generates functional competence-stimulating peptide in Streptococcus mutans UA159. J Bacteriol (2012) 1.07
In silico analysis highlights the frequency and diversity of type 1 lantibiotic gene clusters in genome sequenced bacteria. BMC Genomics (2010) 1.04
Macedocin, a food-grade lantibiotic produced by Streptococcus macedonicus ACA-DC 198. Appl Environ Microbiol (2002) 0.98
The flavoprotein MrsD catalyzes the oxidative decarboxylation reaction involved in formation of the peptidoglycan biosynthesis inhibitor mersacidin. J Bacteriol (2002) 0.93
Site-directed mutations in the lanthipeptide mutacin 1140. Appl Environ Microbiol (2013) 0.92
Distribution of putative virulence genes in Streptococcus mutans strains does not correlate with caries experience. J Clin Microbiol (2011) 0.90
Identification, characterization, and expression of a second, bicistronic, operon involved in the production of lactocin S in Lactobacillus sakei L45. Appl Environ Microbiol (2002) 0.88
Mutacins from Streptococcus mutans UA159 are active against multiple streptococcal species. Appl Environ Microbiol (2011) 0.88
Salivaricin D, a novel intrinsically trypsin-resistant lantibiotic from Streptococcus salivarius 5M6c isolated from a healthy infant. Appl Environ Microbiol (2011) 0.86
SmbFT, a putative ABC transporter complex, confers protection against the lantibiotic Smb in Streptococci. J Bacteriol (2013) 0.81
Mutacin H-29B is identical to mutacin II (J-T8). BMC Microbiol (2006) 0.79
A conserved streptococcal membrane protein, LsrS, exhibits a receptor-like function for lantibiotics. J Bacteriol (2014) 0.79
The leader peptide of mutacin 1140 has distinct structural components compared to related class I lantibiotics. Microbiologyopen (2014) 0.79
Genetic variability of mutans streptococci revealed by wide whole-genome sequencing. BMC Genomics (2013) 0.78
Differential expression of the Smb bacteriocin in Streptococcus mutans isolates. Antimicrob Agents Chemother (2008) 0.77
Genetic classification of severe early childhood caries by use of subtracted DNA fragments from Streptococcus mutans. J Clin Microbiol (2008) 0.77
Biosynthesis and transport of the lantibiotic mutacin 1140 produced by Streptococcus mutans. J Bacteriol (2015) 0.77
Genome mining unveils widespread natural product biosynthetic capacity in human oral microbe Streptococcus mutans. Sci Rep (2016) 0.75
Mutacins of Streptococcus mutans. Braz J Microbiol (2011) 0.75
Comparing the cariogenic species Streptococcus sobrinus and S. mutans on whole genome level. J Oral Microbiol (2014) 0.75
Role of Streptococcus mutans in human dental decay. Microbiol Rev (1986) 17.25
Nucleotide sequence of the Streptococcus faecalis plasmid gene encoding the 3'5"-aminoglycoside phosphotransferase type III. Gene (1983) 8.32
Characterization of the nisin gene cluster nisABTCIPR of Lactococcus lactis. Requirement of expression of the nisA and nisI genes for development of immunity. Eur J Biochem (1993) 5.13
Quorum sensing by peptide pheromones and two-component signal-transduction systems in Gram-positive bacteria. Mol Microbiol (1997) 4.28
Lantibiotics: biosynthesis and biological activities of uniquely modified peptides from gram-positive bacteria. Annu Rev Microbiol (1998) 3.04
Multidrug resistance mediated by a bacterial homolog of the human multidrug transporter MDR1. Proc Natl Acad Sci U S A (1996) 2.53
Biosynthesis and biological activities of lantibiotics with unique post-translational modifications. Eur J Biochem (1995) 2.37
Biosynthesis of the lantibiotic nisin: genomic organization and membrane localization of the NisB protein. Appl Environ Microbiol (1992) 2.18
Analysis of genes involved in biosynthesis of the lantibiotic subtilin. Appl Environ Microbiol (1992) 2.08
Epidermin: sequencing of a heterodetic tetracyclic 21-peptide amide antibiotic. Eur J Biochem (1986) 2.04
Analysis of genes involved in the biosynthesis of lantibiotic epidermin. Eur J Biochem (1992) 1.94
Production and properties of bacteriocins (mutacins) from Streptococcus mutans. Arch Oral Biol (1975) 1.89
Biosynthesis of the lantibiotic subtilin is regulated by a histidine kinase/response regulator system. Appl Environ Microbiol (1993) 1.78
The specific genes for lantibiotic mutacin II biosynthesis in Streptococcus mutans T8 are clustered and can be transferred en bloc. Appl Environ Microbiol (1999) 1.57
Functional analyses of the promoters in the lantibiotic mutacin II biosynthetic locus in Streptococcus mutans. Appl Environ Microbiol (1999) 1.55
Protein engineering of lantibiotics. Antonie Van Leeuwenhoek (1996) 1.54
Structural gene isolation and prepeptide sequence of gallidermin, a new lanthionine containing antibiotic. FEMS Microbiol Lett (1989) 1.53
Distinct bacteriocin groups correlate with different groups of Streptococcus mutans plasmids. Infect Immun (1985) 1.53
Purification and structure of mutacin B-Ny266: a new lantibiotic produced by Streptococcus mutans. FEBS Lett (1997) 1.52
Nucleotide sequence of the lantibiotic Pep5 biosynthetic gene cluster and functional analysis of PepP and PepC. Evidence for a role of PepC in thioether formation. Eur J Biochem (1995) 1.50
The number and nature of , -unsaturated amino acids in subtilin. Biochem Biophys Res Commun (1973) 1.48
Genetic and biochemical analysis of mutacin 1140, a lantibiotic from Streptococcus mutans. Infect Immun (1998) 1.46
Pheromone-induced production of antimicrobial peptides in Lactobacillus. Mol Microbiol (1997) 1.46
Isolation and biochemical characterization of a novel lantibiotic mutacin from Streptococcus mutans. J Bacteriol (1994) 1.45
A bacteriocin-like peptide induces bacteriocin synthesis in Lactobacillus plantarum C11. Mol Microbiol (1995) 1.44
Antagonistic activity of Lactobacillus plantarum C11: two new two-peptide bacteriocins, plantaricins EF and JK, and the induction factor plantaricin A. Appl Environ Microbiol (1998) 1.44
Regulation of epidermin biosynthetic genes by EpiQ. Mol Microbiol (1993) 1.42
Biosynthesis of lantibiotic nisin. Posttranslational modification of its prepeptide occurs at a multimeric membrane-associated lanthionine synthetase complex. J Biol Chem (1996) 1.35
Oxidative decarboxylation of peptides catalyzed by flavoprotein EpiD. Determination of substrate specificity using peptide libraries and neutral loss mass spectrometry. J Biol Chem (1995) 1.32
Isolation, characterization, and heterologous expression of the novel lantibiotic epicidin 280 and analysis of its biosynthetic gene cluster. Appl Environ Microbiol (1998) 1.28
The number and nature of alpha,beta-unsaturated amino acids in nisin. FEBS Lett (1968) 1.27
The subtilin gene of Bacillus subtilis ATCC 6633 is encoded in an operon that contains a homolog of the hemolysin B transport protein. J Bacteriol (1992) 1.27
Immunity to lantibiotics. Antonie Van Leeuwenhoek (1996) 1.24
Growth phase-dependent regulation and membrane localization of SpaB, a protein involved in biosynthesis of the lantibiotic subtilin. Appl Environ Microbiol (1994) 1.21
Enhanced transformation of Streptococcus mutans by modifications in culture conditions. Anal Biochem (1993) 1.16
Preliminary characterization of four bacteriocins from Streptococcus mutans. Can J Microbiol (1990) 1.16
Antibiotics synthesized by posttranslational modification. Annu Rev Microbiol (1993) 1.15
Mutacin II, a bactericidal antibiotic from Streptococcus mutans. Antimicrob Agents Chemother (1995) 1.13
Structure-activity study of the lantibiotic mutacin II from Streptococcus mutans T8 by a gene replacement strategy. Appl Environ Microbiol (1998) 1.10
Mass spectroscopic analysis of a novel enzymatic reaction. Oxidative decarboxylation of the lantibiotic precursor peptide EpiA catalyzed by the flavoprotein EpiD. J Biol Chem (1994) 1.09
Sequence analysis of mutA and mutM genes involved in the biosynthesis of the lantibiotic mutacin II in Streptococcus mutans. Gene (1998) 1.09
Duplication of the lantibiotic structural gene in M-type 49 group A streptococcus strains producing streptococcin A-M49. Appl Environ Microbiol (1994) 1.02
Evidence for a role of NisT in transport of the lantibiotic nisin produced by Lactococcus lactis N8. FEMS Microbiol Lett (1996) 0.96
Serine protease EpiP from Staphylococcus epidermidis catalyzes the processing of the epidermin precursor peptide. J Bacteriol (1996) 0.94
Expression, purification, and characterization of EpiC, an enzyme involved in the biosynthesis of the lantibiotic epidermin, and sequence analysis of Staphylococcus epidermidis epiC mutants. J Bacteriol (1996) 0.90
Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science (1995) 4.41
Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci (2000) 4.14
Dark is a Drosophila homologue of Apaf-1/CED-4 and functions in an evolutionarily conserved death pathway. Nat Cell Biol (1999) 3.45
MicroRNA profile analysis of human prostate cancers. Cancer Gene Ther (2008) 2.43
The fidelity of initial acquisition of mutans streptococci by infants from their mothers. J Dent Res (1995) 2.18
Gene structure and properties of TIGR, an olfactomedin-related glycoprotein cloned from glucocorticoid-induced trabecular meshwork cells. J Biol Chem (1998) 2.13
The group I strain of Streptococcus mutans, UA140, produces both the lantibiotic mutacin I and a nonlantibiotic bacteriocin, mutacin IV. Appl Environ Microbiol (2001) 2.11
Ten-year incidence of dementia in a rural elderly US community population: the MoVIES Project. Neurology (2000) 2.03
Cellular pharmacology and molecular biology of the trabecular meshwork inducible glucocorticoid response gene product. Ophthalmologica (1997) 1.98
Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon. J Biol Chem (1999) 1.90
Chk2 activation dependence on Nbs1 after DNA damage. Mol Cell Biol (2001) 1.85
Mechanisms of GDF-5 action during skeletal development. Development (1999) 1.83
RAM2, an essential gene of yeast, and RAM1 encode the two polypeptide components of the farnesyltransferase that prenylates a-factor and Ras proteins. Proc Natl Acad Sci U S A (1991) 1.74
A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients. Ann Surg (2001) 1.73
Transfer RNA modification: influence on translational frameshifting and metabolism. FEBS Lett (1999) 1.73
Distinct phenotypes distinguish the molecular classes of Angelman syndrome. J Med Genet (2001) 1.71
Vitronectin stabilizes thrombi and vessel occlusion but plays a dual role in platelet aggregation. J Thromb Haemost (2005) 1.70
Mode of delivery and other maternal factors influence the acquisition of Streptococcus mutans in infants. J Dent Res (2005) 1.66
Psychiatric co-morbidity is associated with increased risk of surgery in Crohn's disease. Aliment Pharmacol Ther (2013) 1.64
Genetic profiling of the oral microbiota associated with severe early-childhood caries. J Clin Microbiol (2006) 1.61
Targeted deletion of HIF-1alpha gene in T cells prevents their inhibition in hypoxic inflamed tissues and improves septic mice survival. PLoS One (2007) 1.61
Defect in multiple cell cycle checkpoints in ataxia-telangiectasia postirradiation. J Biol Chem (1996) 1.59
Nephrotic syndrome after treatment with 5-aminosalicylic acid. Br Med J (Clin Res Ed) (1988) 1.59
Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients. Cancer Res (2001) 1.59
EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells. Clin Exp Metastasis (1996) 1.57
The specific genes for lantibiotic mutacin II biosynthesis in Streptococcus mutans T8 are clustered and can be transferred en bloc. Appl Environ Microbiol (1999) 1.57
Functional analyses of the promoters in the lantibiotic mutacin II biosynthetic locus in Streptococcus mutans. Appl Environ Microbiol (1999) 1.55
Bacteriophage T4 RNA ligase is gene 63 product, the protein that promotes tail fiber attachment to the baseplate. Proc Natl Acad Sci U S A (1977) 1.54
Distinct bacteriocin groups correlate with different groups of Streptococcus mutans plasmids. Infect Immun (1985) 1.53
Purification and biochemical characterization of mutacin I from the group I strain of Streptococcus mutans, CH43, and genetic analysis of mutacin I biosynthesis genes. Appl Environ Microbiol (2000) 1.53
COPD in Chinese nonsmokers. Eur Respir J (2009) 1.52
Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms. Drug Metab Dispos (1997) 1.52
Gene dose effect reveals no Gs-coupled A2A adenosine receptor reserve in murine T-lymphocytes: studies of cells from A2A-receptor-gene-deficient mice. Biochem J (2001) 1.49
Altered cytochrome c display precedes apoptotic cell death in Drosophila. J Cell Biol (1999) 1.49
An essential role for the caspase dronc in developmentally programmed cell death in Drosophila. J Biol Chem (2000) 1.46
Virulence of Mycobacterium tuberculosis CDC1551 and H37Rv in rabbits evaluated by Lurie's pulmonary tubercle count method. Infect Immun (1999) 1.46
Plasmodium falciparum strains from Papua New Guinea: culture characteristics and drug sensitivity. Southeast Asian J Trop Med Public Health (1980) 1.46
Isolation and biochemical characterization of a novel lantibiotic mutacin from Streptococcus mutans. J Bacteriol (1994) 1.45
Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines. Cancer Res (2001) 1.44
Localization of a portion of extranuclear ATM to peroxisomes. J Biol Chem (1999) 1.44
Activation of the reaper gene during ectopic cell killing in Drosophila. Dev Biol (1996) 1.44
Determination of the X(3872) meson quantum numbers. Phys Rev Lett (2013) 1.42
Survey of oral microbial diversity using PCR-based denaturing gradient gel electrophoresis. J Dent Res (2005) 1.42
The adequacy of cytology and colposcopy in diagnosing cervical neoplasia in HIV-seropositive women. Gynecol Oncol (1994) 1.40
Idiotypic and subgroup analysis of human monoclonal rheumatoid factors. Implications for structural and genetic basis of autoantibodies in humans. J Clin Invest (1988) 1.38
A 69-year-old woman with recurrent symptomatic pleural effusions. Circulation (1995) 1.38
Effectiveness of steam sterilization in killing spores of Bacillus stearothermophilus in prophylaxis angles. Gen Dent (1996) 1.38
Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures. Antimicrob Agents Chemother (2001) 1.38
Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature. Liver Transpl (2001) 1.35
Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity. Oncogene (1994) 1.35
Incidence of anomalous origin of coronary artery in 1879 Chinese adults on dual-source CT angiography. Neth Heart J (2010) 1.35
Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation. Biochem J (2000) 1.35
Expression of a myosin regulatory light chain phosphorylation site mutant complements the cytokinesis and developmental defects of Dictyostelium RMLC null cells. J Cell Biol (1994) 1.33
Discrepancies in diagnoses of neuroepithelial neoplasms: the San Francisco Bay Area Adult Glioma Study. Cancer (2000) 1.33
Conditional sigma factor expression, using the inducible acetamidase promoter, reveals that the Mycobacterium tuberculosis sigF gene modulates expression of the 16-kilodalton alpha-crystallin homologue. J Bacteriol (1999) 1.32
Characterization of the neuroanatomical distribution of agouti-related protein immunoreactivity in the rhesus monkey and the rat. Endocrinology (1999) 1.31
Arbitrarily primed polymerase chain reaction fingerprinting for the genotypic identification of mutans streptococci from humans. Oral Microbiol Immunol (1998) 1.31
Genotypic diversity of mutans streptococci in Brazilian nursery children suggests horizontal transmission. J Clin Microbiol (2001) 1.29
Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment. Osteoporos Int (2006) 1.29
Localization of osteogenic protein-1 (bone morphogenetic protein-7) during human embryonic development: high affinity binding to basement membranes. Biochem Biophys Res Commun (1994) 1.25
Two distinct tumor suppressor loci within chromosome 11p15 implicated in breast cancer progression and metastasis. Hum Mol Genet (1998) 1.25
Precise control of thermal conductivity at the nanoscale through individual phonon-scattering barriers. Nat Mater (2010) 1.24
Common SNPs and haplotypes in DGKH are associated with bipolar disorder and schizophrenia in the Chinese Han population. Mol Psychiatry (2010) 1.24
The laparoscopic experience of surgical graduates in the United States. Surg Endosc (2003) 1.23
A new enhancer element, ENII, identified in the X gene of hepatitis B virus. J Virol (1990) 1.23
Enhanced prediction of fracture risk combining vertebral fracture status and BMD. Osteoporos Int (2007) 1.22
EGFR overexpression and radiation response in glioblastoma multiforme. Int J Radiat Oncol Biol Phys (2001) 1.21
First observation of CP violation in the decays of B(s)0 mesons. Phys Rev Lett (2013) 1.21
Correlations of partial and extensive methylation at the p14(ARF) locus with reduced mRNA expression in colorectal cancer cell lines and clinicopathological features in primary tumors. Carcinogenesis (2000) 1.21
Predictors of survival after In vivo split liver transplantation: analysis of 110 consecutive patients. Ann Surg (2000) 1.21
Familial clustering of the Streptococcus mutans cryptic plasmid strain in a dental clinic population. Infect Immun (1982) 1.20
Production of osteoclast-activating factor by normal human peripheral blood rosetting and nonrosetting lymphocytes. Eur J Immunol (1976) 1.20
Severity of vertebral fracture reflects deterioration of bone microarchitecture. Osteoporos Int (2006) 1.18
The evolutionary history of carbamoyltransferases: A complex set of paralogous genes was already present in the last universal common ancestor. J Mol Evol (1999) 1.18
Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region of southern China. Clin Genet (2010) 1.17
Differential regulation of two alternatively spliced isoforms of hypoxia-inducible factor-1 alpha in activated T lymphocytes. J Biol Chem (2001) 1.17
Enhanced transformation of Streptococcus mutans by modifications in culture conditions. Anal Biochem (1993) 1.16
Differences in the detection and enumeration of mutans streptococci due to differences in methods. Arch Oral Biol (1995) 1.16
Preliminary characterization of four bacteriocins from Streptococcus mutans. Can J Microbiol (1990) 1.16
Micropressure-flow relationships in a skeletal muscle of spontaneously hypertensive rats. Hypertension (1982) 1.16
Focused ion beam induced deflections of freestanding thin films. J Appl Phys (2006) 1.15
Relationship between duration of teriparatide therapy and clinical outcomes in postmenopausal women with osteoporosis. Osteoporos Int (2008) 1.15
Serine/Threonine kinases 3pK and MAPK-activated protein kinase 2 interact with the basic helix-loop-helix transcription factor E47 and repress its transcriptional activity. J Biol Chem (2000) 1.15
Biocompatibility of engineered nanoparticles for drug delivery. J Control Release (2012) 1.14
Aberrant expression of UCA1 in gastric cancer and its clinical significance. Clin Transl Oncol (2015) 1.13
Mutacin II, a bactericidal antibiotic from Streptococcus mutans. Antimicrob Agents Chemother (1995) 1.13
Waiting list may be a nocebo condition in psychotherapy trials: a contribution from network meta-analysis. Acta Psychiatr Scand (2014) 1.13
Towards structure-based drug design: crystal structure of a multisubstrate adduct complex of glycinamide ribonucleotide transformylase at 1.96 A resolution. J Mol Biol (1995) 1.13
Differentiation of Streptococcus mutans and Streptococcus sobrinus via genotypic and phenotypic profiles from three different populations. Oral Microbiol Immunol (2001) 1.13
Substituted 2-aminopyridines as inhibitors of nitric oxide synthases. Bioorg Med Chem Lett (2000) 1.11
Isolation of full-length ATM cDNA and correction of the ataxia-telangiectasia cellular phenotype. Proc Natl Acad Sci U S A (1997) 1.11
Immune response of guinea pigs to Schistosoma mansoni. I. In vitro effects of antibody and neutrophils, eosinophils and macrophages on schistosomula. Am J Trop Med Hyg (1975) 1.11
Neuroprotective effects of ginsenoside Rb1 on transient cerebral ischemia in rats. Brain Res (2007) 1.11
Plasma membrane-targeted Raf kinase activates NF-kappaB and human immunodeficiency virus type 1 replication in T lymphocytes. J Virol (1998) 1.10
Suppression of Streptococcus mutans in the mouths of humans by a dental prophylaxis and topically-applied iodine. J Dent Res (1979) 1.10